Literature DB >> 19851063

Relation between body fat and liver fat accumulation and cytokine pattern in non-alcoholic patients with chronic HCV infection.

E González-Reimers1, A Castellano-Higuera, R Alemán-Valls, H Alvarez-Argüelles, M J de la Vega-Prieto, P Abreu-González, J López-Prieto, F Santolaria-Fernández, F Valladares-Parrilla.   

Abstract

BACKGROUND: Liver steatosis in chronic hepatitis C virus (HCV) infection is multifactorial. Therefore, there is not necessarily a relation between obesity and liver fat.On the other hand, body fat secretes cytokines, and cytokines and oxidative damage play important roles on progression of liver disease.
METHODS: We analyzed the relationships between liver fat (assessed by histomorphometry) and trunk and subcutaneous fat (waist perimeter, triceps skinfold, BMI); the relationships between liver and body fat and cytokines (IL-6, TNF-alpha, IL-8, IFN-gamma, IL-4), adipokines (adiponectin and TIMP-1), and serum malondiladehyde and antioxidants (glutathione peroxidase and superoxide dismutase (SOD) activities); and the relationships of these data with histological changes in 40 HCV-infected non-alcoholic patients.
RESULTS: Significant correlations were found between liver fat and waist perimeter and BMI, and between serum TIMP-1 and liver fat. Serum TIMP-1 was significantly related to body fat stores; serum IL-6 and IFN-gamma were related to histological inflammation. Patients with waist perimeter >102 cm (men) or 88 cm (women) showed increased liver fat. In 38.8% of non-obese patients, liver fat accumulation was intense.
CONCLUSIONS: There is a relationship between visceral fat, serum TIMP-1 and liver steatosis. However, at least in some patients, factors different from mere adiposity play a role in liver steatosis. Copyright (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19851063     DOI: 10.1159/000252351

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  5 in total

1.  Adipokines, cytokines and body fat stores in hepatitis C virus liver steatosis.

Authors:  Emilio González-Reimers; Javier López-Prieto; Geraldine Quintero-Platt; Ricardo Pelazas-González; M Remedios Alemán-Valls; Onán Pérez-Hernández; M José de-la-Vega-Prieto; M Angeles Gómez-Rodríguez; Candelaria Martín-González; Francisco Santolaria-Fernández
Journal:  World J Hepatol       Date:  2016-01-08

2.  Substitution in Amino Acid 70 of Hepatitis C Virus Core Protein Changes the Adipokine Profile via Toll-Like Receptor 2/4 Signaling.

Authors:  Satoko Uraki; Masahiko Tameda; Kazushi Sugimoto; Katsuya Shiraki; Yoshiyuki Takei; Tsutomu Nobori; Masaaki Ito
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

Review 3.  Metabolic factors and chronic hepatitis C: a complex interplay.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Maria Giovanna Minissale; Teresa Li Vigni; Simona Attardo; Emanuele Orlando; Salvatore Petta
Journal:  Biomed Res Int       Date:  2013-07-17       Impact factor: 3.411

Review 4.  Metabolic aspects of hepatitis C virus.

Authors:  Mohamed El-Kassas; Abeer Awad
Journal:  World J Gastroenterol       Date:  2022-06-14       Impact factor: 5.374

5.  Serum adiponectin in HIV-1 and hepatitis C virus mono- and co-infected Kenyan injection drug users.

Authors:  Eric M Ndombi; Valentine Budambula; Mark K Webale; Francis O Musumba; Jesca O Wesongah; Erick Mibei; Aabid A Ahmed; Raphael Lihana; Tom Were
Journal:  Endocr Connect       Date:  2015-08-25       Impact factor: 3.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.